MedTrace Logo

Screening for Bladder Cancer

NCT00848627 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 197

Last updated 2020-02-25

No results posted yet for this study

Summary

In the study proposed, up to 1,500 men age 60 and over with strong smoking histories will test their urine for the presence of blood daily for two 10-day testing periods with the Ames Hemastix. Individuals with even a solitary positive test will undergo a thorough urologic evaluation to determine the cause of hematuria and follow-up will continue for 2 years after completion of the study.

Conditions

Interventions

OTHER

Specimen and questionnaires only

Specimen and questionnaires only

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    collaborator OTHER

  • University of Rochester

    collaborator OTHER

  • Laval University

    collaborator OTHER

  • Baylor College of Medicine

    lead OTHER

Principal Investigators

  • Seth P. Lerner, MD · Baylor College of Medicine

Eligibility

Min Age
60 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2012-01-31
Completion
2012-02-29

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00848627 on ClinicalTrials.gov